Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
about
Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional studyInduction of P-450 in workers exposed to dioxinMaternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational studyA porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tardaCytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional studyPCB exposure and in vivo CYP1A2 activity among Native AmericansCoffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health StudyMetabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic aminesSignificance of the (13)C-caffeine breath test for patients with cirrhosisGenetic Testing for Opioid Pain Management: A PrimerGenetics of caffeine consumption and responses to caffeine.Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q).Sex-dependent modulation of treatment responseOlanzapine pharmacokinetics are similar in Chinese and Caucasian subjects.Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.Dietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples.Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivoPhenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese populationCaffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans.Comparison of CYP1A2 and NAT2 phenotypes between black and white smokersSerum caffeine and paraxanthine concentrations and menstrual cycle function: correlations with beverage intakes and associations with race, reproductive hormones, and anovulation in the BioCycle StudyGenetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancerCYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics.Time of Day and Training Status Both Impact the Efficacy of Caffeine for Short Duration Cycling Performance.A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.Caffeine induces CYP1A2 expression in rat hepatocytes but not in human hepatocytes.
P2860
Q21195169-19FC34B4-FE5D-4F4F-9FDD-FA7361C48459Q23923467-D96CE618-E919-4EC4-BE1A-BF0D5F67E777Q24645318-260CE875-DB2C-4F33-9A6F-A42330AD52D1Q24681370-262B33E4-CADE-4768-B634-671C7B6DE14AQ24806052-1FCADCF5-A331-462E-A789-6E24750CE50EQ24811520-3E1C3C9B-CAF5-43A3-8F8C-51A3BFCDFA6CQ28387946-03B981AA-9F54-4A77-B26C-AF4753FDDE8DQ28391158-DFE7392C-CD85-4FDE-A322-C9C1C95FFA25Q28657576-235D4FCF-6BB5-441C-987C-FC22F4E56F4BQ33736174-BCC79930-9011-42B7-9559-3CD360C4B736Q34119748-BCEE4DB5-F942-47A2-A761-0087EA60CB3BQ34346940-9E1DBFE8-733C-4848-A84B-065485A4F74EQ34407600-49DA32CD-1E27-4AF4-82CC-C196CDB871FBQ35161304-D6FBF2BE-BEF1-4CF7-AC38-31238A36CCFEQ35236761-ABA724B5-3E26-42F1-B81B-C49CAB1AAB26Q35825477-68642946-4D05-406D-BC9D-DCA57A430EBDQ35825510-6F3B2D31-A40E-4E74-8782-24DA7427CE29Q36053371-FA2C606D-55A3-4056-B858-D65F5B99835EQ36053773-0DEED67F-5E03-42EC-95F9-3F339CEE4774Q36055051-29DF65C8-1AB6-4764-AC7D-41D0940BD3EAQ36063995-C160230E-C36A-419E-B735-6AC58CA89FEBQ37001556-F7892982-96D3-4FE3-A1F1-80865AE00366Q37034587-D2A7162D-4314-4696-AA23-9BDF7E064C6AQ37286958-51AE77AF-EA8A-48E8-A1FE-5944A6433D70Q37305139-A29C723B-FCB3-423E-ABF3-E9F9FE5E559EQ37373953-8781E406-B7D7-4F4B-92D9-878D09BBE6ABQ38646407-DCDFAA94-4CFF-4BFF-BE27-D8864F704397Q41593416-1555DCD0-2EEE-4B49-A409-2D7F1F16AE7AQ42284296-DBCAE2D0-47A5-4A0C-8ACD-9F517DC7DB11Q42705788-80FDBC5F-3935-43F4-9680-C76DFF050978Q43086714-454ED1EA-59EC-4DDE-A9FA-B56147880547
P2860
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@en
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@nl
type
label
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@en
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@nl
prefLabel
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@en
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@nl
P1476
Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.
@en
P304
P407
P433
P577
1991-11-01T00:00:00Z